EP2024497A4 - Liga- und ligb-proteine (leptospiral ig-like (lig)-domänen) zur impfung und diagnose - Google Patents

Liga- und ligb-proteine (leptospiral ig-like (lig)-domänen) zur impfung und diagnose

Info

Publication number
EP2024497A4
EP2024497A4 EP06828120A EP06828120A EP2024497A4 EP 2024497 A4 EP2024497 A4 EP 2024497A4 EP 06828120 A EP06828120 A EP 06828120A EP 06828120 A EP06828120 A EP 06828120A EP 2024497 A4 EP2024497 A4 EP 2024497A4
Authority
EP
European Patent Office
Prior art keywords
leptospire
ligb
liga
lig
immunization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP06828120A
Other languages
English (en)
French (fr)
Other versions
EP2024497A2 (de
Inventor
Marco Alberto Medeiros
Reis Mitemayer Galvao Dos
Silva Everton Fagonde Da
Alan John Alexander Mcbride
Julio Henrique Rosa Croda
Joao Gabriel Rosa Ramos
Odir Antonio Dellagostin
Flavia Weykamp Cruz Mcbride
Albert Icksang Ko
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Fundacao Oswaldo Cruz
Cornell Research Foundation Inc
Original Assignee
Fundacao Oswaldo Cruz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacao Oswaldo Cruz filed Critical Fundacao Oswaldo Cruz
Publication of EP2024497A2 publication Critical patent/EP2024497A2/de
Publication of EP2024497A4 publication Critical patent/EP2024497A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195—Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/20—Assays involving biological materials from specific organisms or of a specific nature from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00—Immunoassays for the detection of microorganisms
    • G01N2469/20—Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Genetics & Genomics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
EP06828120A 2005-12-19 2006-12-19 Liga- und ligb-proteine (leptospiral ig-like (lig)-domänen) zur impfung und diagnose Withdrawn EP2024497A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BRPI0505529-6A BRPI0505529A (pt) 2005-12-19 2005-12-19 proteìnas liga e ligb (leptospiral ig-like(lig) domains) para vacinação e diagnóstico
PCT/BR2006/000283 WO2007070996A2 (en) 2005-12-19 2006-12-19 Liga and ligb proteins (leptospiral ig-like (lig) domains) for vaccination and diagnosis

Publications (2)

Publication Number Publication Date
EP2024497A2 EP2024497A2 (de) 2009-02-18
EP2024497A4 true EP2024497A4 (de) 2010-03-17

Family

ID=38189000

Family Applications (1)

Application Number Title Priority Date Filing Date
EP06828120A Withdrawn EP2024497A4 (de) 2005-12-19 2006-12-19 Liga- und ligb-proteine (leptospiral ig-like (lig)-domänen) zur impfung und diagnose

Country Status (4)

Country Link
EP (1) EP2024497A4 (de)
BR (1) BRPI0505529A (de)
CA (1) CA2634214A1 (de)
WO (1) WO2007070996A2 (de)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003098214A1 (en) * 2002-05-17 2003-11-27 Fundação Oswaldo Cruz - FIOCRUZ Proteins with repetitive bacterial-ig-like (big) domains present in leptospira species
CA2820949C (en) * 2002-10-10 2015-12-08 Cornell Research Foundation, Inc. Novel immunogenic proteins of leptospira

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "UNIPROT:O05734", 1 July 1997 (1997-07-01), XP055325287, Retrieved from the Internet <URL:http://ibis.internal.epo.org/exam/dbfetch.jsp?id=UNIPROT:O05734> [retrieved on 20161201] *
DATABASE EMBL [online] 13 February 2002 (2002-02-13), "Sequence 3 from Patent WO0191536.", XP002565996, retrieved from EBI accession no. EMBL:AX358376 Database accession no. AX358376 *
DATABASE EMBL [online] 25 March 2003 (2003-03-25), "Leptospira interrogans serovar copenhageni putative immunoglobulin-like protein A (ligA) gene, complete cds.", retrieved from EBI accession no. EMBL:AY221109 Database accession no. AY221109 *
DATABASE Geneseq [online] 23 March 2001 (2001-03-23), "Yeast NORF gene SAGE tag oligonucleotide SEQ ID NO:870.", XP002565995, retrieved from EBI accession no. GSN:AAF34131 Database accession no. AAF34131 *
PALANIAPPAN R U M ET AL: "Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans", INFECTION AND IMMUNITY, AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 70, no. 11, 1 November 2002 (2002-11-01), pages 5924 - 5930, XP002348167, ISSN: 0019-9567, DOI: 10.1128/IAI.70.11.5924-5930.2002 *
See also references of WO2007070996A2 *

Also Published As

Publication number Publication date
WO2007070996A3 (en) 2007-09-20
EP2024497A2 (de) 2009-02-18
CA2634214A1 (en) 2007-06-28
WO2007070996A2 (en) 2007-06-28
BRPI0505529A (pt) 2007-09-25

Similar Documents

Publication Publication Date Title
EP1946105A4 (de) Diagnose und beobachtung einer chronischen nierenkrankheit unter verwendung von ngal
EA201100231A1 (ru) Диагностический анализ на основе антител
ATE539069T1 (de) Isotopenmarkierte benzofuranverbindungen als bilddarstellende mittel für amyloidogene proteine
NO20062886L (no) IL-23 og dens reseptor, beslektede reagenser og fremgangsmater
EP1813947A4 (de) Verfahren zur untersuchung von morbus alzheimer und diagnostisches reagens
EP1907018A4 (de) Diagnose und prognose von diabetes
EP2158326A4 (de) Biomarker für die diagnose von autoimmunerkrankungen
DK1712920T3 (da) Tidlig diagnose af konformationelle sygdomme
EP1846015A4 (de) Verfahren, zusammensetzungen und klassifizierung zur tumordiagnose und behandlung
NO982060D0 (no) Ultralydstr÷mningsanalyse med fargeavbildning, sµrlig for medisinsk diagnose
DK1651260T3 (da) Lawsonia intracellularis af europæisk oprindelse og vacciner, diagnostiske midler og fremgangsmåder til anvendelse deraf
EP1806581A4 (de) Krankheitsdiagnosesystem
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
NO20061169L (no) Prober for sykdommer hvor amyloid akkumulerer midler for a farge amyloidlegemidler for behandling og profylakse av sykdommer med akkumulert innhold og prober for diagnoser av nevrofibrilaere knuter og legemidler for a farge nevrofibrilaere knuter
EP2089813A4 (de) Diagnostik und fehlermeldung für häufige tagging-probleme
EP2198292A4 (de) Verbesserte morbus-alzheimer-diagnose
EP1883816A4 (de) Diagnosevorrichtung zur messung des verhältnisses von proteinen mit ähnlicher struktur
EE200300216A (et) Radiofarmatseutilised ained Alzheimeri tõve diagnoosimiseks
EP1907409A4 (de) Verfahren zur diagnose bzw. prognose von in hohem alter auftretenden krankheiten
WO2006090389A3 (en) Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
BRPI0712273A2 (pt) Anticorpos isolados, polipeptídeos imunoglobulinas, anticorpo hepsina, molécula de ácido nucléico, célula hospedeira, linhagem celular, métodos para produzir o anticorpo, para diagnosticar a presença de hepsina, tratar uma doença, para monitorar a doença residual, para detectar o estado da doença, para diagnosticar uma disfunção, composição, arranjo ou chip de proteína e kit
EP1742654A4 (de) Anti-lfl2-antikörper zur diagnose, prognose und behandlung von krebs
EP1573440A4 (de) Verfahren zur diagnose von akathisie
ATE458006T1 (de) Humaner monoklonaler antikörper spezifisch für lipopolysacchariden (lps) des serotyps iats o6 von pseudomonas aeruginosa
EP1781826A4 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von orthopoxviren

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20081107

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR MK RS

RIN1 Information on inventor provided before grant (corrected)

Inventor name: DOS REIS, MITEMAYER, GALVAO

Inventor name: MCBRIDE, ALAN, JOHN, ALEXANDER

Inventor name: RAMOS, JOAO, GABRIEL, ROSA

Inventor name: DA SILVA, EVERTON, FAGONDE

Inventor name: KO, ALBERT, ICKSANG

Inventor name: MCBRIDE, FLAVIA, WEYKAMP, CRUZ

Inventor name: DELLAGOSTIN, ODIR, ANTONIO

Inventor name: CRODA, JULIO, HENRIQUE, ROSA

Inventor name: MEDEIROS, MARCO, ALBERTO

A4 Supplementary search report drawn up and despatched

Effective date: 20100212

17Q First examination report despatched

Effective date: 20100416

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: FUNDACAO OSWALDO CRUZ - FIOCRUZ

Owner name: CORNELL RESEARCH FOUNDATION, INC.

DAX Request for extension of the european patent (deleted)
GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

INTG Intention to grant announced

Effective date: 20180322

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20180802